These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12374628)

  • 1. Different distributions of the 5-HT reuptake complex and the postsynaptic 5-HT(2A) receptors in Brodmann areas and brain hemispheres.
    Rosel P; Arranz B; Urretavizcaya M; Oros M; San L; Vallejo J; Navarro MA
    Psychiatry Res; 2002 Aug; 111(2-3):105-15. PubMed ID: 12374628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower 3H-paroxetine binding in cerebral cortex of suicide victims is partly due to fewer high affinity, non-transporter sites.
    Mann JJ; Henteleff RA; Lagattuta TF; Perper JA; Li S; Arango V
    J Neural Transm (Vienna); 1996; 103(11):1337-50. PubMed ID: 9013420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic effects of triiodothyronine in combination with imipramine on 5-HT transporter, 5-HT(1A) and 5-HT(2A) receptors in adult rat brain.
    Moreau X; Jeanningros R; Mazzola-Pomietto P
    Neuropsychopharmacology; 2001 Jun; 24(6):652-62. PubMed ID: 11331145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stress and antidepressant effects on hippocampal and cortical 5-HT1A and 5-HT2 receptors and transport sites for serotonin.
    Watanabe Y; Sakai RR; McEwen BS; Mendelson S
    Brain Res; 1993 Jun; 615(1):87-94. PubMed ID: 8364729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variations in [3H]imipramine and 5-HT2A but not [3H]paroxetine binding sites in suicide brains.
    Rosel P; Arranz B; Vallejo J; Oros M; Crespo JM; Menchon JM; Navarro MA
    Psychiatry Res; 1998 Jun; 82(3):161-70. PubMed ID: 9754440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of [3H]paroxetine and [3H]cyanoimipramine for quantitative measurement of serotonin transporter sites in human brain.
    Gurevich EV; Joyce JN
    Neuropsychopharmacology; 1996 May; 14(5):309-23. PubMed ID: 8703300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term modulation of presynaptic 5-HT-output: experimentally induced changes in cortical 5-HT-transporter density, tryptophan hydroxylase content and 5-HT innervation density.
    Huether G; Zhou D; Rüther E
    J Neural Transm (Vienna); 1997; 104(10):993-1004. PubMed ID: 9503252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake.
    Bliziotes MM; Eshleman AJ; Zhang XW; Wiren KM
    Bone; 2001 Nov; 29(5):477-86. PubMed ID: 11704501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laterality and 3H-imipramine binding: studies in the frontal cortex of normal controls and suicide victims.
    Arora RC; Meltzer HY
    Biol Psychiatry; 1991 May; 29(10):1016-22. PubMed ID: 1648414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The serotonin transporter from human brain: purification and partial characterization.
    Rotondo A; Giannaccini G; Betti L; Chiellini G; Marazziti D; Martin C; Lucacchini A; Cassano GB
    Neurochem Int; 1996 Mar; 28(3):299-307. PubMed ID: 8813248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT(1B/1D/2) receptor antagonist properties.
    Pullar IA; Boot JR; Carney SL; Cohen ML; Colvin EM; Conway RG; Hardy CH; Lucaites VL; Nelson DL; Schenck KW; Tomlinson R; Wedley S
    Eur J Pharmacol; 2001 Nov; 432(1):9-17. PubMed ID: 11734182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo EEDQ dose-dependently inactivates rat brain 5-HT receptors but not 5-HT uptake sites.
    Pinto W; Battaglia G
    Neuroreport; 1993 Oct; 5(1):61-4. PubMed ID: 8280861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of hypothyroidism on 5-HT1A-, 5-HT2A-receptors and serotonin transporter in the rat brain].
    Kulikov AV; Jeanningro R
    Ross Fiziol Zh Im I M Sechenova; 2000 Mar; 86(3):312-9. PubMed ID: 10808528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet serotonergic binding sites in alcohol-dependent patients.
    Arranz B; Rosel P; Sarró S; Zaldivar E; Cano R; Navarro MA; San L
    Alcohol Alcohol; 1999; 34(5):726-32. PubMed ID: 10528815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims.
    Arango V; Underwood MD; Gubbi AV; Mann JJ
    Brain Res; 1995 Aug; 688(1-2):121-33. PubMed ID: 8542298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain.
    Varnäs K; Halldin C; Hall H
    Hum Brain Mapp; 2004 Jul; 22(3):246-60. PubMed ID: 15195291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin2 receptors and the serotonin transporter in the schizophrenic brain.
    Dean B; Hayes W; Opeskin K; Naylor L; Pavey G; Hill C; Keks N; Copolov DL
    Behav Brain Res; 1996; 73(1-2):169-75. PubMed ID: 8788497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3H]paroxetine binding and serotonin content of rat and rabbit cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region.
    Dewar KM; Reader TA; Grondin L; Descarries L
    Synapse; 1991 Sep; 9(1):14-26. PubMed ID: 1724575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central serotonergic uptake mechanisms in hypertensive rats: effects of clonidine and centhaquin.
    Gulati A; Arora RC; Crayton J
    Eur J Pharmacol; 1993 Feb; 231(2):151-6. PubMed ID: 8453971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet 5-hydroxytryptamine (5-HT) transporter and 5-HT2A receptor binding after chronic hypercorticosteronemia, (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane administration or neurotoxin-induced depletion of central nervous system 5-HT in the rat.
    Owens MJ; Ballenger CA; Knight DL; Nemeroff CB
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1040-9. PubMed ID: 8819484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.